IGF1R and prostate cancer: We had previously demonstrated that IGF-I receptor (IGF-IR) mRNA levels were strikingly elevated in HFD-accelerated LNCaP xenografts and that the group having the lowest IGF-IR immunoreactivity tended to have the lowest body mass index in both human normal and prostate cancer epithelia [16].